Doctor of Podiatric Medicine Program year 2019 Source: CMS Open Payments, 2026 publication

Craig McLaws

Podiatrist, Foot & Ankle Surgery Billings, MT Doctor of Podiatric Medicine

NPI 1295744647 CMS profile 1027024

3990 Avenue D, Billings, MT 59102

Open in the dashboard

General payments

$12

1 record reported · program year 2019

Research payments

$0

Paid to them · None reported · program year 2019

Ownership & investment interest

$0

None reported

Through program year 2019, Craig McLaws of Billings, MT is reported in the CMS Open Payments database as having received $12 across 1 general payment and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 1st percentile of Podiatrist, Foot & Ankle Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

1 row
Year Kind Relative to this record's peak year Amount Records
2019 General $12 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Craig McLaws
  • Podiatrist, Foot & Ankle Surgery median
  • Middle half of Podiatrist, Foot & Ankle Surgery
  • National median

In program year 2025, general payments to Craig McLaws were reported at $0. Among 6,994 Podiatrist, Foot & Ankle Surgery profiles paid that year, the median was $424 and the middle half received between $139 and $1,306.

Show as a table
Year Craig McLaws Podiatrist, Foot & Ankle Surgery median Middle half National median
2019 $12 $389 $118–$1,406 $163
2020 $0 $191 $62–$691 $114
2021 $0 $329 $104–$1,341 $132
2022 $0 $419 $125–$1,611 $149
2023 $0 $377 $128–$1,164 $160
2024 $0 $394 $134–$1,168 $164
2025 $0 $424 $139–$1,306 $169

Breakdown

Who paid General payments · program year 2019
  1. Osiris Therapeutics Inc. $12 1 payment

Every payment, record by record

What the payments were for General payments · program year 2019
  1. Food and Beverage $12 1 payment
Products named General payments · program year 2019
  1. GRAFIX $12 1 payment
  2. Stravix $12 1 payment
  3. GrafixPL $12 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

139

Median for Podiatry: 160

Drug cost

$948

Median for Podiatry: $2,368

Branded share of claims

25.9%

Median for Podiatry: 12.7%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Cephalexin Generic 45 $221
Terbinafine Hcl Generic 14 $164
Gabapentin Generic 15 $148
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 17 $146
Acetaminophen-Codeine Acetaminophen With Codeine Brand 19 $131
Hydralazine Hcl Generic 16 $75
Azithromycin Generic 13 $63

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 14,093 Part D prescribers listed as Podiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 64 billing codes

Paid by Medicare

$132,860

Of which drugs: $839

Medicare patients

365

Average age 76

Services billed

2,265

210 women, 155 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 50%
Diabetes 38%
Depression 27%
Ischemic heart disease 25%
Chronic kidney disease 24%
Atrial fibrillation 21%
Heart failure 18%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 27 181 $118
Injection, dexamethasone sodium phosphate, 1 mg J1100 Office 28 107 $8

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

1 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Podiatrist, Foot & Ankle Surgery in Montana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2019

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record